Nachrichten zur Pfizer Aktie

Acinetobacter Pneumonia Therapeutics Market to Reach USD 927.1 Million to 2031

Companies covered in this study are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), AstraZeneca plc, Novartis AG, Johnson…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Pfizer auf "Neutral" mit einem Kursziel von 30 US-Dollar belassen. Kurzfristig…

Group suing over Pfizer diversity fellowship program loses US appeal By Reuters

Group suing over Pfizer diversity fellowship program loses US appeal…

Pfizer lockt mit 6,4 Prozent Dividendenrendite – jetzt einsteigen?

Mit dem Vertrieb des von BioNTech entwickelten Covid-19-Impfstoff Comirnaty und dem Corona-Medikament Paxlovid hat Pfizer Gewinne in Milliardenhöhe generiert. Die…

Pfizer lockt mit 6,4 Prozent Dividendenrendite – jetzt einsteigen?

Mit dem Vertrieb des von BioNTech entwickelten Covid-19-Impfstoff Comirnaty und dem Corona-Medikament Paxlovid hat Pfizer Gewinne in Milliardenhöhe generiert. Die…

Pfizer: Die hohe Dividende ist sicherlich ein Argument! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…

Pfizer: Onkologie-Pipeline unterbewertet - Aktienanalyse

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse der Citigroup: Andrew Baum, Analyst der Citigroup, nimmt in einer aktuellen Aktienanalyse die Aktie von Pfizer…

Pfizer Inc. (PFE) TD Cowen 44th Annual Health Care Conference

…

6%-Yielding Pfizer Is An Ultra-Deep-Value Gem In An Expensive Market

…

1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $1000. Is It a Buy Around $782?

There are two big reasons why Eli Lilly stock is as much as 5x more expensive than Pfizer.…

KI und Krypto ist ausgereizt! Bio- und NanoTech-Werte auf der Kaufliste: Bayer, BioNTech, Pfizer, BioNxt und FendX Technologies

Die Börse steigt und steigt - so viel verraten die immer neuen Höchststände der prominenten Indizes wie die NASDAQ 100…

Pfizer, Gilead, Roche seen benefitting the most from antibody-drug conjugates

…

Pfizer, looking for a jumpstart, leans into cancer drug research

…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach einer Veranstaltung zum Krebsgeschäft auf "Neutral"…

Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

The results come ahead of a meeting of an advisory panel to the CDC, which will consider whether seniors should…

Pfizer: Buy The Plunge For Rebound Potential And Get Paid A 6% Yield

…

Opening Bell: Wall Street vor Inflationsdaten leichter; Bitcoin bei 60.000 Dollar, Coinbase, Russel 2000, Apple, Viking Therapeutics, Pfizer, Eli Lilly, C3.ai, Beyond Meat im Fokus

Nachdem in der vergangenen Woche Bestmarken erreicht wurden, tun sich die US-Indizes mit einer Fortsetzung der Rally schwer. Schließlich stehen…

Angela Hwang

Angela Hwang closed a major acquisition and created a new integrated oncology division for Pfizer, the culmination of her career…

Pfizer: A Value Trap, Not A Bargain

…

Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst

…

Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst

Income investors can enjoy the nearly 6% dividend yield even if growth doesnt return.…

Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb

The dynamics of the follicular lymphoma market are anticipated to change in the coming years owing to the improvement in…

Pfizer: Kurzfristige Schätzungen könnten steigen, wenn... - Aktienanalyse

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Guggenheim Securities: Guggenheim Securities nimmt in einer aktuellen Aktienanalyse die Coverage der Aktie von Pfizer…

Pfizer: Finally, A Dividend Stock Worth Buying

…

Pfizer files automatic mixed shelf

…

Pfizer Stock Has 29% Upside, Says a New Bull

…

Here are Fridays biggest analyst calls: Rivian, DraftKings, Nio, Fox, Carvana, Pfizer and more

These are some of the biggest calls out of Wall Street on Friday.…

Pfizer stock is the new Buy at Guggenheim By Investing.com

Pfizer stock is the new Buy at Guggenheim…

Guggenheim sets Pfizer stock with buy rating, $36 target By Investing.com

Guggenheim sets Pfizer stock with buy rating, $36 target…

Pharma Stock Roundup: Pfizers Velsipity Receives EU Nod, ABBV Gets New CEO & More

European Commission approves Pfizers (PFE) Velsipity ulcerative colitis (UC) pill. AbbVie (ABBV) appoints Robert A. Michael as the new CEO.…

Pfizers Post-Pandemic Pivot

…

Moderna CEO: Excited About Future Following 4Q Revenue

Moderna Inc. reported fourth-quarter revenue that beat analysts’ expectations by gaining Covid vaccine market share on its rival, Pfizer Inc, posting quarterly…

Pfizer: Turnaround Is Gaining Momentum

…

Pfizers (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

The approval for Pfizers (PFE) Velsipity (etrasimod) is based on data from two pivotal phase III studies, ELEVATE UC 52…

Pfizers Expansion Sparks Boom for these Healthcare REITs

…

Pharmakonzern Daiichi Sankyo investiert eine Mrd Euro in Bayern

München (Reuters) - Der japanische Pharmakonzern Daiichi Sankyo will sein Werk im bayerischen Pfaffenhofen an der Ilm für eine Milliarde…

How To Earn $1,000 Per Month From Pfizer Stock

…

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

PALM BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous reports indicate…

Pfizer Stock: Its Time To Buy The Dip

…

Pfizer touts cancer efforts in first Super Bowl commercial

…

Pfizer Is A Great Investment Over The Next Decade; Buy

…

Pharma Stocks: 5 Biggest Companies in 2024

The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…

Pfizer might get Alzheimers lift from Viagra, study suggests

Pfizer had some rare good news in a tough twelve months for the US pharma as a new study suggested…

How To Earn $500 Per Month From Pfizer Stock

…

Pfizers Problems Go Far Beyond Just Declining COVID Revenue

…

Pfizer: Auf der Suche nach Wachstum - Aktienanalyse

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

Hemostasis Products Market revenue to hit USD 1.73 Billion by 2033, says Research Nester

Prominent hemostasis products market players include Terumo Corporation, Baxter International, Inc., Sysmex Asia Pacific Pte Ltd, Abbott Healthcare Private Limited,…

Better Dividend Stock: Pfizer vs. AbbVie @themotleyfool #stocks $ABBV $PFE

Both offer above-average yields but which can deliver the most dividend income over the long run?…

Better Dividend Stock: Pfizer vs. AbbVie

…

Better Dividend Stock: Pfizer vs. AbbVie

Both offer above-average yields but which can deliver the most dividend income over the long run?…